Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.190
0.00 (0.00%)
Sep 24, 2026, 10:27 AM EDT - Market open
Serina Therapeutics Revenue
In the year 2025, Serina Therapeutics had annual revenue of $130.00K with 132.14% growth.
Revenue (ttm)
$130.00K
Revenue Growth
+132.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
55.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 130.00K | 74.00K | 132.14% |
| Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
| Dec 31, 2023 | 3.15M | 3.12M | 9,173.53% |
| Dec 31, 2022 | 34.00K | -110.00K | -76.39% |
| Dec 31, 2021 | 144.00K | -217.00K | -60.11% |
| Dec 31, 2020 | 361.00K | -1.37M | -79.11% |
| Dec 31, 2019 | 1.73M | 332.00K | 23.78% |
| Dec 31, 2018 | 1.40M | -8.00K | -0.57% |
| Dec 31, 2017 | 1.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 151.18M |
| Xilio Therapeutics | 64.09M |
| Hyperion DeFi | 1.40M |
| ImageneBio | 800.00K |
| Clene | 197.00K |
| INmune Bio | 50.00K |
| Impact BioMedical | 35.00K |
| eXoZymes | -700.00 |
SER News
- 18 hours ago - Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "A New Approach to Advanced Parkinson's Disease: Serina Discusses SER-252's Clinical Progress" - GlobeNewsWire
- 13 days ago - Serina Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 13 days ago - Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 14 days ago - Serina Therapeutics Slides: Investor presentation - Filings
- 15 days ago - Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson's Disease and Advances to Cohort 2 - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics files to sell 12.5M shares of common stock for holders - TheFly
- 4 weeks ago - Serina Therapeutics Registration statement: Registration filing - Filings
- 5 weeks ago - Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire